Aris Global announced that invivodata has been selected as its preferred partner for ePRO solutions.
invivodata’s ePRO solutions–DiaryPRO® for field-based data collection and SitePRO® for in-clinic based data collection – will provide complementary functionality to Aris Global’s Total Clinical™ suite of integrated solutions, which includes agCapture™ for electronic data capture, ARISg™ for drug safety, agXchange and agClinical™ for clinical trial management. Total Clinical enables companies to enter data once and share across their enterprise. The Total Clinical suite is available on a hosted, managed platform and includes a full range of delivery and support services.
Aris Global’s strategy is to partner with solution providers currently serving the growing ePRO market. invivodata’s ePRO solutions are consistent with Aris Global’s standards of customer service.
“We are very excited about our partnership with invivodata,” said Dr. Sylva H. Collins, vice president, Total Clinical Solutions at Aris Global. “The use of invivodata’s ePRO system brings scientific and regulatory credibility in capturing the patient’s experience in a clinical trial.” “Aris Global’s Total Clinical suite offers value to clinical researchers,” said Doug Engfer, president and CEO at invivodata. “We look forward to working with them and aligning our eClinical solutions to further help life science organizations meet regulatory guidelines, manage risk and improve operational efficiencies.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.